HCM
BIIB icon

Howard Capital Management’s Biogen BIIB Stock Holding History

Howard Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,161
Closed -$204K – 343
2025
Q4 		$204K Buy
+1,161
New +$190K ﹤0.01% 423
2025
Q3 		– Sell
-4,442
Closed -$558K – 424
2025
Q2 		$558K Buy
4,442
+450
+11% +$56.1K 0.01% 278
2025
Q1 		$546K Sell
3,992
-610
-13% -$87.2K 0.01% 254
2024
Q4 		$704K Buy
4,602
+153
+3% +$25.8K 0.01% 257
2024
Q3 		$862K Buy
+4,449
New +$931K 0.01% 223

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Howard Capital Management's BIIB Position: Q1 2026 in Review

Howard Capital Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 1,161 shares — an estimated $204K sold.

Howard Capital Management first reported a position in BIIB in Q3 2024 and held it in 5 quarters. The position peaked at $862K in Q3 2024. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Howard Capital Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Howard Capital Management sold 1,161 Biogen shares in Q1 2026, an estimated $204K.
  • Howard Capital Management first reported a position in Biogen in Q3 2024 and held it in 5 quarters.
  • Howard Capital Management's Biogen position peaked at $862K in Q3 2024.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Howard Capital Management's 13F filing for Q1 2026, filed 5 May 2026.